MHRA
- Status: likely_approved
🇬🇧 Sunpg 1622 in United Kingdom
Sunpg 1622 (TILDRAKIZUMAB) regulatory status in United Kingdom.
Marketing authorisations
MHRA
- Status: likely_approved
Sunpg 1622 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United Kingdom
Frequently asked questions
Is Sunpg 1622 approved in United Kingdom?
Yes. MHRA has authorised it; MHRA has authorised it.
Who is the marketing authorisation holder for Sunpg 1622 in United Kingdom?
Sun Pharma Global is the originator. The local marketing authorisation holder may differ — check the official source linked above.